TaiGen Biopharmaceuticals Holdings (ROCO:4157) YoY EPS Growth : -200.00% (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is TaiGen Biopharmaceuticals Holdings YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. TaiGen Biopharmaceuticals Holdings's YoY EPS Growth for the quarter that ended in Mar. 2025 was -200.00%.

TaiGen Biopharmaceuticals Holdings's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was NT$-0.03.

TaiGen Biopharmaceuticals Holdings YoY EPS Growth Historical Data

The historical data trend for TaiGen Biopharmaceuticals Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiGen Biopharmaceuticals Holdings YoY EPS Growth Chart

TaiGen Biopharmaceuticals Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

-36.59

292.86

-130.56

157.58

-126.32

TaiGen Biopharmaceuticals Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EPS Growth	Get a 7-Day Free Trial															85.71	800.00	-900.00	-113.13	-200.00

TaiGen Biopharmaceuticals Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

TaiGen Biopharmaceuticals Holdings's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(-0.05	-	0.19)	/	\| 0.19 \|
=	-126.32 %

TaiGen Biopharmaceuticals Holdings's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (Q: Mar. 2025 )
=	(Earnings per Share (Diluted) (Q: Mar. 2025 )	-	Earnings per Share (Diluted) (Q: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2024 )) \|
=	(-0.03	-	-0.01)	/	\| -0.01 \|
=	-200.00 %

TaiGen Biopharmaceuticals Holdings YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of TaiGen Biopharmaceuticals Holdings's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiGen Biopharmaceuticals Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiGen Biopharmaceuticals Holdings Ltd (ROCO:4157) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 138 Xinming Road, 7th Floor, Neihu District, Taipei, TWN, 114

Website

https://www.taigenbiotech.com/tw

TaiGen Biopharmaceuticals Holdings Ltd is mainly engaged in the research and development of new drugs, including the selection of drug candidates, pre-IND trials and clinical trials. Its operating segment includes development, research and sales of new drugs, and other.

TaiGen Biopharmaceuticals Holdings Headlines

No Headlines